Related Experiment Video
Updated: Jun 27, 2026
05:23
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Cost-effectiveness analysis: what it really means for transfusion medicine decision making
1Blood Systems Research Institute, San Francisco, CA; St Michael's Hospital, Toronto, Ontario, Canada. bcuster@bloodsystems.org
Transfusion Medicine Reviews
|December 6, 2008
Summary
Cost-effectiveness analysis (CEA) is crucial in transfusion medicine, despite claims that "blood is different." Ignoring CEA in blood safety can lead to significant mortality and morbidity due to resource misallocation.
Area of Science:
- Health Economics
- Transfusion Medicine
Background:
- Economic evaluation, specifically cost-effectiveness analysis (CEA), is often debated in transfusion medicine.
- Some argue that the unique nature of blood products limits the applicability of CEA.
Purpose of the Study:
- To review key concepts of health economics and economic analysis methods.
- To explore the application and impact of CEA in transfusion medicine and blood safety.
- To discuss the implications of opportunity cost in resource allocation for blood safety.
Main Methods:
- Review of fundamental principles of health economics and CEA.
- Analysis of published studies on blood safety and economic evaluations.
- Examination of decision-making processes in transfusion medicine.
Main Results:
- Economic thinking is demonstrably present in various aspects of transfusion medicine.
- CEA results from blood safety studies provide context for decision-making.
- Ignoring CEA in blood safety decisions can result in substantial increases in mortality and morbidity.
Conclusions:
- CEA plays a vital role in optimizing resource allocation within transfusion medicine.
- Opportunity cost in blood safety should be understood as the societal willingness to misallocate resources, leading to suboptimal health outcomes.
- The impact of CEA varies, highlighting the need for its consistent consideration in transfusion medicine policy and practice.
Related Concept Videos
01:15Blood Transfusion
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:16Bioequivalence Data: Statistical Interpretation
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...